Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Pulmonary Hypertension

  Free Subscription


2 Aging (Albany NY)
1 Am Heart J
1 Ann Am Thorac Soc
1 Biomark Med
1 Blood
2 Circ Heart Fail
2 Curr Probl Cardiol
1 Emerg Radiol
1 ERJ Open Res
1 Eur Heart J Cardiovasc Imaging
1 Eur J Pediatr
1 Eur Rev Med Pharmacol Sci
1 Expert Rev Cardiovasc Ther
1 FP Essent
1 Front Cardiovasc Med
1 Front Physiol
1 Heart
1 Int J Cardiol
1 Int J Gen Med
1 J Biochem Mol Toxicol
1 J Bras Pneumol
1 J Thorac Dis
1 J Vet Cardiol
2 JACC Cardiovasc Imaging
4 Pulm Circ
1 Pulmonology
1 Rheumatology (Oxford)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aging (Albany NY)

  1. ZHOU XL, Huang FJ, Li Y, Huang H, et al
    SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.
    Aging (Albany NY). 2021;13:7538-7548.
    PubMed         Abstract available

  2. DONG H, Li X, Cai M, Zhang C, et al
    Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension.
    Aging (Albany NY). 2021;13:14234-14257.
    PubMed         Abstract available

    Am Heart J

  3. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    PubMed         Abstract available

    Ann Am Thorac Soc

    Riding the Ferrous Wheel of Iron Supplementation in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2021;18:946-948.

    Biomark Med

  5. KERANOV S, Dorr O, Jafari L, Liebetrau C, et al
    Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension.
    Biomark Med. 2021 Jul 22. doi: 10.2217/bmm-2021-0009.
    PubMed         Abstract available


  6. SHARMA S, Hofbauer TM, Ondracek AS, Chausheva S, et al
    Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis.
    Blood. 2021;137:1104-1116.
    PubMed         Abstract available

    Circ Heart Fail

  7. HARDIN EA, Araj FG
    Letter by Hardin and Araj Regarding Article, "Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study".
    Circ Heart Fail. 2021;14:e008158.

  8. VIRAY MC, Bonno EL, Houston BA, Tedford RJ, et al
    Response by Viray et al to Letter Regarding Article, "Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study".
    Circ Heart Fail. 2021;14:e008304.

    Curr Probl Cardiol

  9. NAVARRO-VERGARA DI, Roldan-Valadez E, Cueto-Robledo G, Jurado-Hernandez MY, et al
    Portopulmonary Hypertension: Prevalence, Clinical and Hemodynamic Features.
    Curr Probl Cardiol. 2021;46:100747.
    PubMed         Abstract available

  10. RAWAL H, Suman A, Bhoite RR, Kanwal A, et al
    Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer?
    Curr Probl Cardiol. 2021;46:100738.
    PubMed         Abstract available

    Emerg Radiol

    Reply to letter to editor: Association between pulmonary arterial obstruction index and right lateral ventricular wall thickness with in-hospital mortality in patients with acute pulmonary embolism.
    Emerg Radiol. 2021;28:865.

    ERJ Open Res

  12. HASSAN HJ, Housten T, Balasubramanian A, Simpson CE, et al
    A novel approach to perioperative risk assessment for patients with pulmonary hypertension.
    ERJ Open Res. 2021;7.
    PubMed         Abstract available

    Eur Heart J Cardiovasc Imaging

  13. GUO X, Lai J, Wang H, Tian Z, et al
    Predictive value of non-invasive right ventricle to pulmonary circulation coupling in systemic lupus erythematosus patients with pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2021;22:111-118.
    PubMed         Abstract available

    Eur J Pediatr

  14. FORTAS F, Di Nardo M, Yousef N, Humbert M, et al
    Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.
    Eur J Pediatr. 2021;180:2379-2387.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  15. NIJIATI Y, Maimaitiyiming D, Yang T, Li H, et al
    Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora.
    Eur Rev Med Pharmacol Sci. 2021;25:4540-4553.
    PubMed         Abstract available

    Expert Rev Cardiovasc Ther

  16. BARRADAS-PIRES A, Constantine A, Dimopoulos K
    Preventing disease progression in Eisenmenger syndrome.
    Expert Rev Cardiovasc Ther. 2021;19:501-518.
    PubMed         Abstract available


  17. MENG L, Yuan W, Chi H, Han R, et al
    Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension.
    FASEB J. 2021;35:e21421.
    PubMed         Abstract available

    FP Essent

  18. BARZIN A
    Heart Failure: Right-Sided Heart Failure.
    FP Essent. 2021;506:27-30.
    PubMed         Abstract available

    Front Cardiovasc Med

  19. LI Y, Guo D, Gong J, Wang J, et al
    Right Ventricular Function and Its Coupling With Pulmonary Circulation in Precapillary Pulmonary Hypertension: A Three-Dimensional Echocardiographic Study.
    Front Cardiovasc Med. 2021;8:690606.
    PubMed         Abstract available

    Front Physiol

  20. HARROD KK, Rogers JL, Feinstein JA, Marsden AL, et al
    Predictive Modeling of Secondary Pulmonary Hypertension in Left Ventricular Diastolic Dysfunction.
    Front Physiol. 2021;12:666915.
    PubMed         Abstract available


  21. LIM K, Yang JH, Miranda WR, Chang SA, et al
    Clinical significance of pulmonary hypertension in patients with constrictive pericarditis.
    Heart. 2021 Jul 20. pii: heartjnl-2021-319149. doi: 10.1136/heartjnl-2021-319149
    PubMed         Abstract available

    Int J Cardiol

  22. SUN X, Wang C, Liu Y, Chen X, et al
    Clinical impact of new diagnostic criteria for postcapillary pulmonary hypertension.
    Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01183.

    Int J Gen Med

  23. TILEA I, Petra DN, Serban RC, Gabor MR, et al
    Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center.
    Int J Gen Med. 2021;14:3355-3366.
    PubMed         Abstract available

    J Biochem Mol Toxicol

  24. KAYMAK E, Akin AT, Tufan E, Basaran KE, et al
    The effect of chloroquine on the TRPC1, TRPC6, and CaSR in the pulmonary artery smooth muscle cells in hypoxia-induced experimental pulmonary artery hypertension.
    J Biochem Mol Toxicol. 2021;35:e22636.
    PubMed         Abstract available

    J Bras Pneumol

  25. OTA-ARAKAKI JS, Campos FTAF, Souza R
    World Pulmonary Hypertension Day: reflections and planning.
    J Bras Pneumol. 2021;47:e20210251.

    J Thorac Dis

  26. SUN Y, Wang L, Meng X, Gong S, et al
    Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension.
    J Thorac Dis. 2021;13:3478-3488.
    PubMed         Abstract available

    J Vet Cardiol

  27. CADDIGAN S, Granlund B, Sakarin S, Rungsipipat A, et al
    Histopathological changes of pulmonary vascular remodeling in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    J Vet Cardiol. 2021;36:141-152.
    PubMed         Abstract available

    JACC Cardiovasc Imaging

  28. MAIER A, Liao SL, Lescure T, Robson PM, et al
    Pulmonary Artery (18)F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis.
    JACC Cardiovasc Imaging. 2021 Jul 8. pii: S1936-878X(21)00488.
    PubMed         Abstract available

  29. BADAGLIACCA R, Pezzuto B, Papa S, Poscia R, et al
    Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension.
    JACC Cardiovasc Imaging. 2021;14:162-172.
    PubMed         Abstract available

    Pulm Circ

  30. ANTHI A, Tsiapras D, Karyofyllis P, Voudris V, et al
    The wide spectrum of beta-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy.
    Pulm Circ. 2021;11:20458940211030490.
    PubMed         Abstract available

  31. TANIGUCHI H, Takashima T, Tu L, Thuillet R, et al
    Pulmonary hypertension associated with neurofibromatosis type 2.
    Pulm Circ. 2021;11:20458940211029550.
    PubMed         Abstract available

  32. BAJOLLE F, Malekzadeh-Milani S, Levy M, Bonnet D, et al
    Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and BMPR-2 mutation.
    Pulm Circ. 2021;11:20458940211027433.
    PubMed         Abstract available

  33. WANG L, Shen L, Zhao YL, Pudasaini B, et al
    Survival in severe pulmonary hypertension due to chronic lung disease: influence of in-hospital platelet distribution width.
    Pulm Circ. 2021;11:20458940211026484.
    PubMed         Abstract available


  34. MUSTAFAOGLU R, Demir R, Aslan GK, Sinan UY, et al
    Translation, cross-cultural adaptation, reliability, and validity of the Turkish version of the Duke Activity Status Index in patients with pulmonary hypertension.
    Pulmonology. 2021 Jul 16. pii: S2531-0437(21)00130.

    Rheumatology (Oxford)

  35. SHOWALTER K, Pinheiro LC, Jannat-Khah D, Sobol I, et al
    Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry.
    Rheumatology (Oxford). 2021 Jul 17. pii: 6323372.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.